These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 22149035)

  • 1. Protein biomarkers of ovarian cancer: the forest and the trees.
    Nolen BM; Lokshin AE
    Future Oncol; 2012 Jan; 8(1):55-71. PubMed ID: 22149035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian Cancer Biomarkers: Moving Forward in Early Detection.
    Bonifácio VDB
    Adv Exp Med Biol; 2020; 1219():355-363. PubMed ID: 32130708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Detection of Ovarian Cancer.
    Elias KM; Guo J; Bast RC
    Hematol Oncol Clin North Am; 2018 Dec; 32(6):903-914. PubMed ID: 30390764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and application of protein biomarkers for ovarian cancer.
    Gagnon A; Ye B
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):9-13. PubMed ID: 18196999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer.
    Ryu J; Thomas SN
    Molecules; 2021 May; 26(9):. PubMed ID: 34063568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal biomarkers in the early detection of ovarian cancer.
    Galea M; Gauci G; Calleja-Agius J; Schembri-Wismayer P
    Minerva Ginecol; 2017 Feb; 69(1):84-99. PubMed ID: 27284942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care.
    Shadfan BH; Simmons AR; Simmons GW; Ho A; Wong J; Lu KH; Bast RC; McDevitt JT
    Cancer Prev Res (Phila); 2015 Jan; 8(1):37-48. PubMed ID: 25388014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for ovarian cancer in the general population.
    Gentry-Maharaj A; Menon U
    Best Pract Res Clin Obstet Gynaecol; 2012 Apr; 26(2):243-56. PubMed ID: 22182415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular signatures of ovarian cancer: from detection to prognosis.
    Walsh CS; Karlan BY
    Mol Diagn Ther; 2010 Feb; 14(1):13-22. PubMed ID: 20121286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for early detection of ovarian cancer.
    Nguyen L; Cardenas-Goicoechea SJ; Gordon P; Curtin C; Momeni M; Chuang L; Fishman D
    Womens Health (Lond); 2013 Mar; 9(2):171-85; quiz 186-7. PubMed ID: 23477323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for a system: the quest for ovarian cancer biomarkers.
    Rodland KD; Maihle NJ
    Cancer Biomark; 2010-2011; 8(4-5):223-30. PubMed ID: 22045355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis.
    Wang X; Kong D; Wang C; Ding X; Zhang L; Zhao M; Chen J; Xu X; Hu X; Yang J; Gao S
    J Ovarian Res; 2019 Mar; 12(1):24. PubMed ID: 30898156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early stage detection and screening of ovarian cancer: A research opportunity and significant challenge for biosensor technology.
    Franier B; Thompson M
    Biosens Bioelectron; 2019 Jun; 135():71-81. PubMed ID: 31003031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. -The advancement of biomarker-based diagnostic tools for ovarian, breast, and pancreatic cancer through the use of urine as an analytical biofluid.
    Nolen BM; Lokshin AE
    Int J Biol Markers; 2011; 26(3):141-52. PubMed ID: 21928247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor markers for early detection of ovarian cancer.
    Ren J; Cai H; Li Y; Zhang X; Liu Z; Wang JS; Hwa YL; Zhang Y; Yang Y; Li Y; Jiang SW
    Expert Rev Mol Diagn; 2010 Sep; 10(6):787-98. PubMed ID: 20843202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.
    Tamir A; Jag U; Sarojini S; Schindewolf C; Tanaka T; Gharbaran R; Patel H; Sood A; Hu W; Patwa R; Blake P; Chirina P; Oh Jeong J; Lim H; Goy A; Pecora A; Suh KS
    J Ovarian Res; 2014 Dec; 7():109. PubMed ID: 25477184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
    Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
    PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sine qua non of discovering novel biomarkers for early detection of ovarian cancer: carefully selected preclinical samples.
    Jacobs I; Menon U
    Cancer Prev Res (Phila); 2011 Mar; 4(3):299-302. PubMed ID: 21372028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics of ovarian cancer: functional insights and clinical applications.
    Elzek MA; Rodland KD
    Cancer Metastasis Rev; 2015 Mar; 34(1):83-96. PubMed ID: 25736266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of ovarian cancer.
    Teneriello MG; Park RC
    CA Cancer J Clin; 1995; 45(2):71-87. PubMed ID: 7889392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.